155 related articles for article (PubMed ID: 3391264)
1. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
Yu QS; Atack JR; Rapoport SI; Brossi A
FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
[TBL] [Abstract][Full Text] [Related]
2. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
Atack JR; Yu QS; Soncrant TT; Brossi A; Rapoport SI
J Pharmacol Exp Ther; 1989 Apr; 249(1):194-202. PubMed ID: 2709330
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.
Yu QS; Atack JR; Rapoport SI; Brossi A
J Med Chem; 1988 Dec; 31(12):2297-300. PubMed ID: 3193422
[TBL] [Abstract][Full Text] [Related]
4. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
5. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
Galli A; Malmberg Aiello P; Renzi G; Bartolini A
J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
[TBL] [Abstract][Full Text] [Related]
7. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
Brossi A; Schönenberger B; Clark OE; Ray R
FEBS Lett; 1986 Jun; 201(2):190-2. PubMed ID: 3709808
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
[TBL] [Abstract][Full Text] [Related]
12. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
13. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine.
Galli A; Renzi G; Grazzini E; Bartolini R; Aiello-Malmberg P; Bartolini A
Biochem Pharmacol; 1982 Apr; 31(7):1233-8. PubMed ID: 7092918
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
17. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
[TBL] [Abstract][Full Text] [Related]
18. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Rakonczay Z
Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
[TBL] [Abstract][Full Text] [Related]
19. Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors.
Bolognesi ML; Andrisano V; Bartolini M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 2001 Jan; 44(1):105-9. PubMed ID: 11141093
[TBL] [Abstract][Full Text] [Related]
20. Anticholinesterase action of 3-diethylaminophenyl-N-methyl-carbamate methiodide in vitro and in vivo.
Bajgar J; Patocka J
Acta Biol Med Ger; 1976; 35(3-4):479-84. PubMed ID: 970052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
